Cancer Genetics Flashcards

1
Q

Cancer

A

Uncontrolled cell proliferation, disease of cellular differentiation, normal growth and differentiation disrupted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Genetic causes of cancer

A

Changes occur in genes that regulate proliferation, may be caused by mutagenic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Environmental causes of cancer

A

Carcinogens can be environmental, cancer frequencies change with environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Inherited cancer

A

Mutations can occur in germline, inherited by subsequent generations, predisposes to cancer- one step on pathway to cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Knudson’s two-hit model

A

Retinoblastoma- bilateral (runs in families), unilateral (appears sporadically), need two mutations for cancer, one copy bad already in inherited form, sporadic requires two events in one cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tumor suppressor genes

A

Normally control cell cycle and proliferation, RB1, CDK inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Oncogenes

A

Enhance cell proliferation when activated, few inherited mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

DNA repair genes

A

Help maintain integrity of genome, BRCA1, BRCA2, mismatch repair genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Inheritance paradox

A

Mutations appear to be dominant in inheritance pattern, are recessive at cellular level (require second copy to be mutated), truly dominant forms are lethal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mapping cancer genes

A

Tumor cells compared to normal cells, look for areas of consistent change, heterozygous loci are studied, lost markers indicate loss of heterozygosity (LOH) near gene of interest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Loss of heterozygosity (LOH)

A

Markers in different regions, two forms each in normal cells, missing markers indicate LOH, give probable location of the gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Refining the gene map

A

Mutations in several families examined, narrow the region with linkage studies, look for anomalies in that region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Refining of neurofibromatosis 1 (NF1) gene

A

Two different translocations in region, only 50 kb apart, interrupt the same gene, structure suggests role in cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Chromosome considerations

A

Tumors often have abnormal chromosomes, aneuploidy, translocations, may contribute to tumor progression, may arise from mutations in DNA repair or cell cycle control genes, telomerase may be activated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Telomerase and cancer

A

Maintain telomere length, prevent aging, normal cells become aged after 50-70 divisions, low telomerase activity means shortening of telomeres and limits on division, active telomerase means immortal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Neurofibromatosis 1 (NF1)

A

Skin lesions, “cafe au lait spots”, large tumors may develop, dominant gene on chromosome 17, tumor suppressor, similar to GTPase activating protein (GAP), down-regulates RAS signaling

17
Q

TP53 gene

A

Codes for p53 protein, mutations found in over half of all tumors, loss of 17p in colon tumor cells common, small deletions localize to TP53 region, most are missense, mainly in DNA binding domain of protein

18
Q

p53 function

A

Binds to CDKN1A (p21) promoter, increases p21 level, inhibits cell cycle, involved in DNA damage sensing, directs damaged cells to undergo apoptosis, interacts with PTEN and BAX

19
Q

Action of p53

A

Transcription factor regulating cell cycle, DNA repair, and programmed death, p53 senses DNA damage (or hypoxia), halts the cell cycle so new DNA synthesis will not replicate the damaged DNA, up-regulates genes involved in DNA repair, stimulates apoptosis if damage is severe

20
Q

Li-Fraumeni syndrome

A

Inherited TP53 mutation, high frequency of a variety of cancers in families, many tissues show tumors- breast, colon, adrenocortical carcinomas, soft tissue sarcomas, osteosarcomas, brain tumors, leukemia

21
Q

Familial adenomatous polyposis coli

A

Familial colon cancer, gene termed APC, inhibits beta-catenin, adenomas start as polyps, can progress to malignancy

22
Q

Hereditary non-polyposis colon cancer

A

Familial colon cancer, disease termed HNPCC, many fewer polyps, other tumors common

23
Q

APC and colon cancer

A

Tumor suppressor gene, loss of second copy causes polyp formation, APC gene mutated in 85% of sporadic cases, loss not sufficient for cancer progression

24
Q

Multi-step model of cancer progression

A

First hit- APC mutation, down regulates beta-catenin, myc signal transduction, causes proliferation, early adenoma
Second- K-RAS activation, gain of function, signal transduction
Third- TP53 mutation common
Fourth- other genes altered, SMAD4, genes leading to metastasis

25
Q

HNPCC genes

A

1-5% of colorectal cancer, 70-90% penetrance in heterozygotes, other cancers fairly common, mutations in MSH2, MLH1 are most common, all involved in DNA mismatch repair, loss of function increases mutation rate

26
Q

APC vs. HNPCC

A

APC has more polyps, low probability of malignancy, number of polyps increases odds of tumor, HNPCC has few polyps, probability of further mutation high, increases probability of tumor progressing

27
Q

Breast cancer

A

BRCA1, BRCA2 account for 1-3% of cancers, family history increases to 20%, history of breast and ovarian cancer 60-80%, mutation increases lifetime risk, BRCA2 increases breast cancer risk in men

28
Q

BRCA gene function

A

Repairing double-stranded DNA breaks, BRCA1 phosphorylated, binds BRCA2, RAD51

29
Q

Familial melanoma

A

Risk increases with affected relative, 5-10% due to familial forms, some linked to CDKN2A, CDK inhibitor known as p16, inhibits CDK4 like p21, mutated in 25% of sporadic melanomas, CDK4 gain of function mutations also seen

30
Q

Multiple endocrine neoplasia (MEN)

A

MEN2 is inherited form (3 subtypes), RET gene mutated, receptor tyrosine kinase, activated one of few oncogenes that shows inherited cancer, each subtype shows characteristic mutations, loss of function mutations cause developmental anomalies

31
Q

Genes and common cancers

A

Most cancers are sporadic, not inherited, much familial clustering unexplained, increased risk is known, knowledge of cancer to identify pathways and alterations